[
  {
    "ts": null,
    "headline": "Incyte Corp. stock outperforms competitors on strong trading day",
    "summary": "Incyte Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=971398b8757ae84d1c2177638af8c1fb5e5cbaaec4fd98cbdc099f0f6a07e2cb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740417420,
      "headline": "Incyte Corp. stock outperforms competitors on strong trading day",
      "id": 132926208,
      "image": "",
      "related": "INCY",
      "source": "MarketWatch",
      "summary": "Incyte Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=971398b8757ae84d1c2177638af8c1fb5e5cbaaec4fd98cbdc099f0f6a07e2cb"
    }
  },
  {
    "ts": null,
    "headline": "Compass Therapeutics: Good Execution, Major Catalysts Ahead",
    "summary": "Explore Compass Therapeutics' tovecimig trials, upcoming Phase 3 BTC data, and market insights.",
    "url": "https://finnhub.io/api/news?id=b1469714b8e1c61deb53e8fba05f5cf8f889f5b64ca602e00bfacb2523690455",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740392127,
      "headline": "Compass Therapeutics: Good Execution, Major Catalysts Ahead",
      "id": 132864016,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1688767071/image_1688767071.jpg?io=getty-c-w1536",
      "related": "INCY",
      "source": "SeekingAlpha",
      "summary": "Explore Compass Therapeutics' tovecimig trials, upcoming Phase 3 BTC data, and market insights.",
      "url": "https://finnhub.io/api/news?id=b1469714b8e1c61deb53e8fba05f5cf8f889f5b64ca602e00bfacb2523690455"
    }
  }
]